{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T21:57:07Z","timestamp":1792101427180,"version":"4.4.0"},"reference-count":84,"publisher":"Oxford University Press (OUP)","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2002,11]]},"DOI":"10.1093\/brain\/awf251","type":"journal-article","created":{"date-parts":[[2002,10,21]],"date-time":"2002-10-21T18:46:52Z","timestamp":1035226012000},"page":"2431-2445","source":"Crossref","is-referenced-by-count":383,"title":["Clinical correlates of selective pathology in the amygdala of patients with Parkinson\u2019s disease"],"prefix":"10.1093","volume":"125","author":[{"given":"Antony J.","family":"Harding","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Stimson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jasmine M.","family":"Henderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Glenda M.","family":"Halliday","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2002,11]]},"reference":[{"key":"key\n\t\t\t\t20170624065651_AWF251C1","doi-asserted-by":"crossref","unstructured":"Adolphs R, Tranel D, Damasio H, Damasio A. Impaired recognition of emotion in facial expressions following bilateral damage to the human amygdala. Nature1994; 372: 669\u201372.","DOI":"10.1038\/372669a0"},{"key":"key\n\t\t\t\t20170624065651_AWF251C2","unstructured":"Aggleton JP. The functional effects of amygdala lesions in humans: A comparison with findings from monkeys. In: Aggleton JP, editor. The amygdala: neurobiological aspects of emotion, memory, and mental dysfunction. New York: Wiley\u2010Liss; 1992. p. 485\u2013503."},{"key":"key\n\t\t\t\t20170624065651_AWF251C3","unstructured":"American Psychiatric Association. Diagnostic and statistical manual of mental disorders: DSM\u2010IV. 4th ed. Washington (DC): American Psychiatric Association; 1994."},{"key":"key\n\t\t\t\t20170624065651_AWF251C4","unstructured":"Anderson AK, Phelps EA. Intact recognition of vocal expressions of fear following bilateral lesions of human amygdala. Neuroreport1998; 9: 3607\u201313."},{"key":"key\n\t\t\t\t20170624065651_AWF251C5","doi-asserted-by":"crossref","unstructured":"Anderton BH. Changes in the ageing brain in health and disease. [Review]. Philos Trans R Soc Lond B Biol Sci1997; 352: 1781\u201392.","DOI":"10.1098\/rstb.1997.0162"},{"key":"key\n\t\t\t\t20170624065651_AWF251C6","doi-asserted-by":"crossref","unstructured":"Bancaud J, Brunet\u2010Bourgin F, Chauvel P, Halgren E. Anatomical origin of deja vu and vivid \u2018memories\u2019 in human temporal lobe epilepsy. Brain1994; 117: 71\u201390.","DOI":"10.1093\/brain\/117.1.71"},{"key":"key\n\t\t\t\t20170624065651_AWF251C7","doi-asserted-by":"crossref","unstructured":"Braak H, Braak E. Neuropathological stageing of Alzheimer\u2010related changes. [Review]. Acta Neuropathol (Berl)1991; 82: 239\u201359.","DOI":"10.1007\/BF00308809"},{"key":"key\n\t\t\t\t20170624065651_AWF251C8","doi-asserted-by":"crossref","unstructured":"Braak H, Braak E, Yilmazer D, de Vos R, Jansen E, Bohl J, et al. Amygdala pathology in Parkinson\u2019s disease. Acta Neuropathol (Berl)1994; 88: 493\u2013500.","DOI":"10.1007\/BF00296485"},{"key":"key\n\t\t\t\t20170624065651_AWF251C9","unstructured":"Braak H, Braak E, Yilmazer D, Schultz C, de Vos RAI, Jansen EN. Nigral and extranigral pathology in Parkinson\u2019s disease. [Review]. J Neural Transm1995; Suppl 46: 15\u201331."},{"key":"key\n\t\t\t\t20170624065651_AWF251C10","doi-asserted-by":"crossref","unstructured":"Broks P, Young AW, Maratos EJ, Coffey PJ, Calder AJ, Isaac CL et al. Face processing impairments after encephalitis: amygdala damage and recognition of fear. Neuropsychologia1998; 36: 59\u201370.","DOI":"10.1016\/S0028-3932(97)00105-X"},{"key":"key\n\t\t\t\t20170624065651_AWF251C11","doi-asserted-by":"crossref","unstructured":"Cahill L, Babinsky R, Markowitsch HJ, McGaugh JL. The amygdala and emotional memory. Nature1995; 377: 295\u20136.","DOI":"10.1038\/377295a0"},{"key":"key\n\t\t\t\t20170624065651_AWF251C12","doi-asserted-by":"crossref","unstructured":"Churchyard A, Lees AJ. The relationship between dementia and direct involvement of the hippocampus and amygdala in Parkinson\u2019s disease. Neurology1997; 49: 1570\u20136.","DOI":"10.1212\/WNL.49.6.1570"},{"key":"key\n\t\t\t\t20170624065651_AWF251C13","doi-asserted-by":"crossref","unstructured":"Cordato NJ, Halliday GM, Harding AJ, Hely MA, Morris JG. Regional brain atrophy in progressive supranuclear palsy and Lewy body disease. Ann Neurol2000; 47: 718\u201328.","DOI":"10.1002\/1531-8249(200006)47:6<718::AID-ANA4>3.0.CO;2-J"},{"key":"key\n\t\t\t\t20170624065651_AWF251C14","doi-asserted-by":"crossref","unstructured":"Darvesh S, Grantham DL, Hopkins DA. Distribution of butyrylcholinesterase in the human amygdala and hippocampal formation. J Comp Neurol1998; 393: 374\u201390.","DOI":"10.1002\/(SICI)1096-9861(19980413)393:3<374::AID-CNE8>3.0.CO;2-Z"},{"key":"key\n\t\t\t\t20170624065651_AWF251C15","doi-asserted-by":"crossref","unstructured":"Davidson RJ, Pizzagalli D, Nitschke JB, Putnam K. Depression: perspectives from affective neuroscience. [Review]. Annu Rev Psychol2002; 53: 545\u201374.","DOI":"10.1146\/annurev.psych.53.100901.135148"},{"key":"key\n\t\t\t\t20170624065651_AWF251C16","doi-asserted-by":"crossref","unstructured":"Davis DG, Schmitt FA, Wekstein DR, Markesbery WR. Alzheimer neuropathologic alterations in aged cognitively normal subjects. J Neuropathol Exp Neurol1999; 58: 376\u2013388.","DOI":"10.1097\/00005072-199904000-00008"},{"key":"key\n\t\t\t\t20170624065651_AWF251C17","doi-asserted-by":"crossref","unstructured":"de la Monte SM, Wells SE, Hedley\u2010Whyte E, Growdon JH. Neuropathological distinction between Parkinson\u2019s dementia and Parkinson\u2019s plus Alzheimer\u2019s disease. Ann Neurol1989; 26: 309\u201320.","DOI":"10.1002\/ana.410260302"},{"key":"key\n\t\t\t\t20170624065651_AWF251C18","doi-asserted-by":"crossref","unstructured":"de Olmos JS. Amygdala. In: Paxinos G, editor. The human nervous system. San Diego: Academic Press; 1990. p. 583\u2013710.","DOI":"10.1016\/B978-0-12-547625-6.50025-8"},{"key":"key\n\t\t\t\t20170624065651_AWF251C19","doi-asserted-by":"crossref","unstructured":"Dickson DW. Pick\u2019s disease: A modern approach. [Review]. Brain Pathol1998; 8: 339\u201354.","DOI":"10.1111\/j.1750-3639.1998.tb00158.x"},{"key":"key\n\t\t\t\t20170624065651_AWF251C20","doi-asserted-by":"crossref","unstructured":"Dickson DW. Tau and synuclein and their role in neuropathology. [Review]. Brain Pathol1999; 9: 657\u201361.","DOI":"10.1111\/j.1750-3639.1999.tb00548.x"},{"key":"key\n\t\t\t\t20170624065651_AWF251C21","doi-asserted-by":"crossref","unstructured":"Doty RL, Deems DA, Stellar S. Olfactory dysfunction in parkinsonism: a general deficit unrelated to neurologic signs, disease stage, or disease duration. Neurology1988; 38: 1237\u201344.","DOI":"10.1212\/WNL.38.8.1237"},{"key":"key\n\t\t\t\t20170624065651_AWF251C22","doi-asserted-by":"crossref","unstructured":"Double KL, Halliday GM, McRitchie DA, Reid WG, Hely MA, Morris JG. Regional brain atrophy in idiopathic Parkinson\u2019s disease and diffuse Lewy body disease. Dementia1996; 7: 304\u201313.","DOI":"10.1159\/000106896"},{"key":"key\n\t\t\t\t20170624065651_AWF251C23","doi-asserted-by":"crossref","unstructured":"Drevets WC. Neuroimaging and neuropathological studies of depression: implications for the cognitive\u2010emotional features of mood disorders. [Review]. Curr Opin Neurobiol2001; 11: 240\u20139.","DOI":"10.1016\/S0959-4388(00)00203-8"},{"key":"key\n\t\t\t\t20170624065651_AWF251C24","doi-asserted-by":"crossref","unstructured":"Fearnley JM, Lees AJ. Ageing and Parkinson\u2019s disease: substantia nigra regional selectivity. Brain1991; 114: 2283\u2013301.","DOI":"10.1093\/brain\/114.5.2283"},{"key":"key\n\t\t\t\t20170624065651_AWF251C25","doi-asserted-by":"crossref","unstructured":"F\u00e9nelon G, Mahieux F, Huon R, Zi\u00e9gler M. Hallucinations in Parkinson\u2019s disease. Prevalence, phenomenology and risk factors. Brain2000; 123: 733\u201345.","DOI":"10.1093\/brain\/123.4.733"},{"key":"key\n\t\t\t\t20170624065651_AWF251C26","doi-asserted-by":"crossref","unstructured":"Gelb DJ, Oliver E, Gilman S. Diagnostic criteria for Parkinson\u2019s disease. Arch Neurol1999; 56: 33\u20139.","DOI":"10.1001\/archneur.56.1.33"},{"key":"key\n\t\t\t\t20170624065651_AWF251C27","unstructured":"Gloor P. The amygdaloid system. In: Gloor P. The temporal lobe and limbic system. New York: Oxford University Press; 1997. p. 591\u2013721."},{"key":"key\n\t\t\t\t20170624065651_AWF251C28","doi-asserted-by":"crossref","unstructured":"Gorno\u2010Tempini ML, Pradelli S, Serafini M, Pagnoni G, Baraldi P, Porro C, et al. Explicit and incidental facial expression processing: an fMRI study. Neuroimage2001; 14: 465\u201373.","DOI":"10.1006\/nimg.2001.0811"},{"key":"key\n\t\t\t\t20170624065651_AWF251C29","doi-asserted-by":"crossref","unstructured":"Gray TS. Functional and anatomical relationships among the amygdala, basal forebrain, ventral striatum, and cortex. An integrative discussion. [Review]. Ann NY Acad Sci1999; 877: 439\u201344.","DOI":"10.1111\/j.1749-6632.1999.tb09281.x"},{"key":"key\n\t\t\t\t20170624065651_AWF251C30","doi-asserted-by":"crossref","unstructured":"Hague K, Lento P, Morgello S, Caro S, Kaufmann H. The distribution of Lewy bodies in pure autonomic failure: autopsy findings and review of the literature. [Review]. Acta Neuropathol (Berl)1997; 94: 192\u20136.","DOI":"10.1007\/s004010050693"},{"key":"key\n\t\t\t\t20170624065651_AWF251C31","doi-asserted-by":"crossref","unstructured":"Halliday GM, McRitchie DA, Cartwright H, Pamphlett R, Hely MA, Morris JGL. Midbrain neuropathology in idiopathic Parkinson\u2019s disease and diffuse Lewy body disease. J Clin Neurosci1996; 3: 52\u201360.","DOI":"10.1016\/S0967-5868(96)90083-1"},{"key":"key\n\t\t\t\t20170624065651_AWF251C32","doi-asserted-by":"crossref","unstructured":"Hamilton RL. Lewy bodies in Alzheimer\u2019s disease: a neuropathological review of 145 cases using \u03b1\u2010synuclein immunohistochemistry. Brain Pathol2000; 10: 378\u201384.","DOI":"10.1111\/j.1750-3639.2000.tb00269.x"},{"key":"key\n\t\t\t\t20170624065651_AWF251C33","doi-asserted-by":"crossref","unstructured":"Harding AJ, Halliday GM. Simplified neuropathological diagnosis of dementia with Lewy bodies. Neuropathol Appl Neurobiol1998; 24: 195\u2013201.","DOI":"10.1046\/j.1365-2990.1998.00115.x"},{"key":"key\n\t\t\t\t20170624065651_AWF251C34","doi-asserted-by":"crossref","unstructured":"Harding, AJ, Halliday GM. Cortical Lewy body pathology in the diagnosis of dementia. Acta Neuropathol (Berl)2001; 102: 355\u201363.","DOI":"10.1007\/s004010100390"},{"key":"key\n\t\t\t\t20170624065651_AWF251C35","doi-asserted-by":"crossref","unstructured":"Harding AJ, Halliday GM, Cullen K. Practical considerations for the use of the optical disector in estimating neuronal number. J Neurosci Methods1994; 51: 83\u20139.","DOI":"10.1016\/0165-0270(94)90028-0"},{"key":"key\n\t\t\t\t20170624065651_AWF251C36","doi-asserted-by":"crossref","unstructured":"Harding AJ, Kril JJ, Halliday GM. Practical measures to simplify the Braak tangle staging method for routine pathological screening. Acta Neuropathol (Berl)2000; 99: 199\u2013208.","DOI":"10.1007\/PL00007425"},{"key":"key\n\t\t\t\t20170624065651_AWF251C37","doi-asserted-by":"crossref","unstructured":"Harding AJ, Broe GA, Halliday GM. Visual hallucinations in Lewy body disease relate to Lewy bodies in the temporal lobe. Brain2002a; 125: 391\u2013403.","DOI":"10.1093\/brain\/awf033"},{"key":"key\n\t\t\t\t20170624065651_AWF251C38","doi-asserted-by":"crossref","unstructured":"Harding AJ, Lakay B, Halliday GM. Selective hippocampal neuron loss in dementia with Lewy bodies. Ann Neurol2002b; 51: 125\u20138.","DOI":"10.1002\/ana.10071"},{"key":"key\n\t\t\t\t20170624065651_AWF251C39","doi-asserted-by":"crossref","unstructured":"Hawkes CH, Shephard BC. Selective anosmia in Parkinson\u2019s disease? Lancet1993; 341: 435\u2013436.","DOI":"10.1016\/0140-6736(93)93027-X"},{"key":"key\n\t\t\t\t20170624065651_AWF251C40","doi-asserted-by":"crossref","unstructured":"Henderson JM, Carpenter K, Cartwright H, Halliday GM. Degeneration of the centre\u2010median\u2010parafascicular complex in Parkinson\u2019s disease. Ann Neurol2000; 47: 345\u201352.","DOI":"10.1002\/1531-8249(200003)47:3<345::AID-ANA10>3.0.CO;2-V"},{"key":"key\n\t\t\t\t20170624065651_AWF251C41","doi-asserted-by":"crossref","unstructured":"Henderson JM, Gai WP, Hely MA, Reid WG, Walker GL, Halliday GM. Parkinson\u2019s disease with late Pick\u2019s dementia. Mov Disord2001; 16: 311\u20139.","DOI":"10.1002\/mds.1053"},{"key":"key\n\t\t\t\t20170624065651_AWF251C42","doi-asserted-by":"crossref","unstructured":"Hoehn MM, Yahr MD. Parkinsonism: onset, progression and mortality. Neurology1967; 17: 427\u201342.","DOI":"10.1212\/WNL.17.5.427"},{"key":"key\n\t\t\t\t20170624065651_AWF251C43","doi-asserted-by":"crossref","unstructured":"Hurtig HI, Trojanowski JQ, Galvin J, Ewbank D, Schmidt ML, Lee VM\u2010Y, et al. Alpha\u2010synuclein cortical Lewy bodies correlate with dementia in Parkinson\u2019s disease. Neurology2000; 54: 1916\u201321.","DOI":"10.1212\/WNL.54.10.1916"},{"key":"key\n\t\t\t\t20170624065651_AWF251C44","doi-asserted-by":"crossref","unstructured":"Imamura T, Ishii K, Hirono N, Hashimoto M, Tanimukai S, Kazuai H, et al. Visual hallucinations and regional cerebral metabolism in dementia with Lewy bodies (DLB). Neuroreport1999; 10: 1903\u20137.","DOI":"10.1097\/00001756-199906230-00020"},{"key":"key\n\t\t\t\t20170624065651_AWF251C45","doi-asserted-by":"crossref","unstructured":"Iseki E, Odawara T, Li F, Kosaka K, Nishimura T, Akiyama H, et al. Age\u2010related ubiquitin\u2010positive granular structures in non\u2010demented subjects and neurodegenerative disorders. J Neurol Sci1996; 142: 25\u20139.","DOI":"10.1016\/0022-510X(96)00024-X"},{"key":"key\n\t\t\t\t20170624065651_AWF251C46","doi-asserted-by":"crossref","unstructured":"Iseki E, Kato M, Marui W, U\u00e9da K, Kosaka K. A neuropathological study of the disturbance of the nigro\u2010amygdaloid connections in brains from patients with dementia with Lewy bodies. J Neurol Sci2001; 185: 129\u201334.","DOI":"10.1016\/S0022-510X(01)00481-6"},{"key":"key\n\t\t\t\t20170624065651_AWF251C47","doi-asserted-by":"crossref","unstructured":"Jacobs DH, Shuren J, Bowers D, Heilman KM. Emotional facial imagery, perception, and expression in Parkinson\u2019s disease. Neurology1995; 45: 1696\u2013702.","DOI":"10.1212\/WNL.45.9.1696"},{"key":"key\n\t\t\t\t20170624065651_AWF251C48","doi-asserted-by":"crossref","unstructured":"Kanazawa I. How do neurons die in neurodegenerative diseases? Trends Mol Med2001; 7: 339\u2013344.","DOI":"10.1016\/S1471-4914(01)02017-2"},{"key":"key\n\t\t\t\t20170624065651_AWF251C49","doi-asserted-by":"crossref","unstructured":"Kim H, Gearing M, Mirra SS. Ubiquitin\u2010positive CA2\/3 neurites in hippocampus coexist with cortical Lewy bodies. Neurology1995; 45: 1768\u201370.","DOI":"10.1212\/WNL.45.9.1768"},{"key":"key\n\t\t\t\t20170624065651_AWF251C50","doi-asserted-by":"crossref","unstructured":"Lippa CF, Fujiwara H, Mann DM, Giasson B, Baba M, Schmidt ML, et al. Lewy bodies contain altered alpha\u2010synuclein in brains of many familial Alzheimer\u2019s disease patients with mutations in presenilin and amyloid precursor protein genes. Am J Pathol1998; 153: 1365\u201370.","DOI":"10.1016\/S0002-9440(10)65722-7"},{"key":"key\n\t\t\t\t20170624065651_AWF251C51","doi-asserted-by":"crossref","unstructured":"Lippa CF, Schmidt ML, Lee VM, Trojanowski JQ. Antibodies to alpha\u2010synuclein detect Lewy bodies in many Down\u2019s syndrome brains with Alzheimer\u2019s disease. Ann Neurol1999; 45: 353\u20137.","DOI":"10.1002\/1531-8249(199903)45:3<353::AID-ANA11>3.0.CO;2-4"},{"key":"key\n\t\t\t\t20170624065651_AWF251C52","doi-asserted-by":"crossref","unstructured":"Lovestone S, McLoughlin DM. Protein aggregates and dementia: is there a common toxicity? [Review]. J Neurol Neurosurg Psychiatry2002; 72: 152\u201361.","DOI":"10.1136\/jnnp.72.2.152"},{"key":"key\n\t\t\t\t20170624065651_AWF251C53","doi-asserted-by":"crossref","unstructured":"Maccioni RB, Munoz JP, Barbeito L. The molecular bases of Alzheimer\u2019s disease and other neurodegenerative disorders. [Review]. Arch Med Res2001; 32: 367\u201381.","DOI":"10.1016\/S0188-4409(01)00316-2"},{"key":"key\n\t\t\t\t20170624065651_AWF251C54","doi-asserted-by":"crossref","unstructured":"Mann DM. Anosmia in dementia is associated with Lewy bodies rather than Alzheimer\u2019s pathology. J Neurol Neurosurg Psychiatry2001; 70: 720\u20131.","DOI":"10.1136\/jnnp.70.6.720"},{"key":"key\n\t\t\t\t20170624065651_AWF251C55","doi-asserted-by":"crossref","unstructured":"Mattila PM, Rinne JO, Helenius H, Dickson DW, R\u00f6ytt\u00e4 M. Alpha\u2010synuclein\u2010immunoreactive cortical Lewy bodies are associated with cognitive impairment in Parkinson\u2019s disease. Acta Neuropathol (Berl)2000; 100: 285\u201390.","DOI":"10.1007\/s004019900168"},{"key":"key\n\t\t\t\t20170624065651_AWF251C56","doi-asserted-by":"crossref","unstructured":"McKeith IG, Galasko D, Kosaka K, Perry EK, Dickson DW, Hansen LA, et al. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. [Review]. Neurology1996; 47: 1113\u201324.","DOI":"10.1212\/WNL.47.5.1113"},{"key":"key\n\t\t\t\t20170624065651_AWF251C57","doi-asserted-by":"crossref","unstructured":"McShane RH, Nagy Z, Esiri MM, King E, Joachim C, Sullivan N, et al. Anosmia in dementia is associated with Lewy bodies rather than Alzheimer\u2019s pathology. J Neurol Neurosurg Psychiatry2001; 70: 739\u201343.","DOI":"10.1136\/jnnp.70.6.739"},{"key":"key\n\t\t\t\t20170624065651_AWF251C58","doi-asserted-by":"crossref","unstructured":"Mesholam RI, Moberg PJ, Mahr RN, Doty RL. Olfaction in neurodegenerative diseases. Arch Neurol1998; 55: 84\u201390.","DOI":"10.1001\/archneur.55.1.84"},{"key":"key\n\t\t\t\t20170624065651_AWF251C59","doi-asserted-by":"crossref","unstructured":"Mirra SS, Heyman A, McKeel D, Sumi SM, Crain BJ, Brownlee LM, et al. The Consortium to Establish a Registry for Alzheimer\u2019s Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer\u2019s disease. Neurology1991; 41: 479\u201386.","DOI":"10.1212\/WNL.41.4.479"},{"key":"key\n\t\t\t\t20170624065651_AWF251C60","doi-asserted-by":"crossref","unstructured":"Morris JC, Heyman A, Mohs RC, Hughes JP, van Belle G, Fillenbaum G, et al. The Consortium to Establish a Registry for Alzheimer\u2019s Disease (CERAD). Part I. Clinical and neuropsychological assessment of Alzheimer\u2019s disease. Neurology1989; 39: 1159\u201365.","DOI":"10.1212\/WNL.39.9.1159"},{"key":"key\n\t\t\t\t20170624065651_AWF251C61","doi-asserted-by":"crossref","unstructured":"Morris JS, DeGelder B, Weiskrantz L, Dolan RJ. Differential extrageniculostriate and amygdala responses to presentation of emotional faces in a cortically blind field. Brain2001; 124: 1241\u201352.","DOI":"10.1093\/brain\/124.6.1241"},{"key":"key\n\t\t\t\t20170624065651_AWF251C62","doi-asserted-by":"crossref","unstructured":"National Institute on Aging and Reagan Institute Working Group on Diagnostic Criteria for the Neuropathological Assessment of Alzheimer\u2019s Disease. Consensus recommendations for the postmortem diagnosis of Alzheimer\u2019s disease. [Review]. Neurobiol Aging1997; 18 (4 Suppl): S1\u20132.","DOI":"10.1016\/S0197-4580(97)00057-2"},{"key":"key\n\t\t\t\t20170624065651_AWF251C63","doi-asserted-by":"crossref","unstructured":"Pearce RK, Hawkes CH, Daniel SE. The anterior olfactory nucleus in Parkinson\u2019s disease. Mov Disord1995; 10: 283\u20137.","DOI":"10.1002\/mds.870100309"},{"key":"key\n\t\t\t\t20170624065651_AWF251C64","doi-asserted-by":"crossref","unstructured":"Petrovich GD, Canteras NS, Swanson LW. Combinatorial amygdalar inputs to hippocampal domains and hypothalamic behavior systems. [Review]. Brain ResBrain Res Rev2001; 1: 247\u201389.","DOI":"10.1016\/S0165-0173(01)00080-7"},{"key":"key\n\t\t\t\t20170624065651_AWF251C65","unstructured":"Poewe W, Luginger E. Depression in Parkinson\u2019s disease: impediments to recognition and treatment options. [Review]. Neurology1999; 52 (7 Suppl 3): S2\u20136."},{"key":"key\n\t\t\t\t20170624065651_AWF251C66","doi-asserted-by":"crossref","unstructured":"Potogas C, Dellatolas G, Ziegler M, Leveteau J, Bathien N, MacLeod P, et al. Clinical assessment of olfactory dysfunction in Parkinson\u2019s disease. Mov Disord1998; 13: 394\u20139.","DOI":"10.1002\/mds.870130304"},{"key":"key\n\t\t\t\t20170624065651_AWF251C67","doi-asserted-by":"crossref","unstructured":"Rezaie P, Cairns NJ, Chadwick A, Lantos PL. Lewy bodies are located preferentially in limbic areas in diffuse Lewy body disease. Neurosci Lett1996; 212: 111\u20134.","DOI":"10.1016\/0304-3940(96)12775-0"},{"key":"key\n\t\t\t\t20170624065651_AWF251C68","doi-asserted-by":"crossref","unstructured":"Rosenkranz JA, Grace AA. Cellular mechanisms of infralimbic and prelimbic prefrontal cortical inhibition and dopaminergic modulation of basolateral amygdala neurons in vivo. J Neurosci2002; 22: 324\u201337.","DOI":"10.1523\/JNEUROSCI.22-01-00324.2002"},{"key":"key\n\t\t\t\t20170624065651_AWF251C69","doi-asserted-by":"crossref","unstructured":"Santhouse AM, Howard RJ, ffytche DH. Visual hallucinatory syndromes and the anatomy of the visual brain. Brain2000; 123: 2055\u201364.","DOI":"10.1093\/brain\/123.10.2055"},{"key":"key\n\t\t\t\t20170624065651_AWF251C70","doi-asserted-by":"crossref","unstructured":"Schmidt ML, Martin JA, Lee VM, Trojanowski JQ. Convergence of Lewy bodies and neurofibrillary tangles in amygdala neurons of Alzheimer\u2019s disease and Lewy body disorders. Acta Neuropathol (Berl)1996; 91: 475\u201381.","DOI":"10.1007\/s004010050454"},{"key":"key\n\t\t\t\t20170624065651_AWF251C71","doi-asserted-by":"crossref","unstructured":"Shekhar A, Sajdyk TS, Keim SR, Yoder KK, Sanders SK. Role of the basolateral amygdala in panic disorder. Ann NY Acad Sci1999; 877: 747\u201350.","DOI":"10.1111\/j.1749-6632.1999.tb09315.x"},{"key":"key\n\t\t\t\t20170624065651_AWF251C72","doi-asserted-by":"crossref","unstructured":"Sims KS, Williams RS. The human amygdaloid complex: a cytologic and histochemical atlas using Nissl, myelin, acetylcholinesterase and nicotinamide adenine dinucleotide phosphate diaphorase staining. Neuroscience1990; 36: 449\u201372.","DOI":"10.1016\/0306-4522(90)90440-F"},{"key":"key\n\t\t\t\t20170624065651_AWF251C73","doi-asserted-by":"crossref","unstructured":"Smith MC, Smith MK, Ellgring H. Spontaneous and posed facial expression in Parkinson\u2019s disease. J Int Neuropsychol Soc1996; 2: 383\u201391.","DOI":"10.1017\/S1355617700001454"},{"key":"key\n\t\t\t\t20170624065651_AWF251C74","doi-asserted-by":"crossref","unstructured":"Swanson LW. Cerebral hemisphere regulation of motivated behavior. [Review]. Brain Res2000; 886: 113\u201364.","DOI":"10.1016\/S0006-8993(00)02905-X"},{"key":"key\n\t\t\t\t20170624065651_AWF251C75","doi-asserted-by":"crossref","unstructured":"Swanson LW, Petrovich GD. What is the amygdala? [Review]. Trends Neurosci1998; 21: 323\u2013331.","DOI":"10.1016\/S0166-2236(98)01265-X"},{"key":"key\n\t\t\t\t20170624065651_AWF251C76","doi-asserted-by":"crossref","unstructured":"Tebartz van Elst L, Ebert D, Trimble MR. Hippocampus and amygdala pathology in depression [letter]. Am J Psychiatry2001; 158: 652\u20133.","DOI":"10.1176\/appi.ajp.158.4.652-a"},{"key":"key\n\t\t\t\t20170624065651_AWF251C77","doi-asserted-by":"crossref","unstructured":"Tebartz van Elst L, Baeumer D, Lemieux L, Woermann FG, Koepp M, Krishnamoorthy S, et al. Amygdala pathology in psychosis of epilepsy. A magnetic resonance imaging study in patients with temporal lobe epilepsy. Brain2002; 125: 140\u20139.","DOI":"10.1093\/brain\/awf008"},{"key":"key\n\t\t\t\t20170624065651_AWF251C78","doi-asserted-by":"crossref","unstructured":"Terry RD. Do neuronal inclusions kill the cell? [Review]. J Neural Transm2000; Suppl 59: 91\u20133.","DOI":"10.1007\/978-3-7091-6781-6_12"},{"key":"key\n\t\t\t\t20170624065651_AWF251C79","doi-asserted-by":"crossref","unstructured":"Tissingh G, Berendse HW, Bergmans P, DeWaard R, Drukarch B, Stoof JC, et al. Loss of olfaction in de novo and treated Parkinson\u2019s disease: possible implications for early diagnosis. Mov Disord2001; 16: 41\u20136.","DOI":"10.1002\/1531-8257(200101)16:1<41::AID-MDS1017>3.0.CO;2-M"},{"key":"key\n\t\t\t\t20170624065651_AWF251C80","doi-asserted-by":"crossref","unstructured":"Wakabayashi K, Takahashi H. Neuropathology of autonomic nervous system in Parkinson\u2019s disease. [Review]. Eur Neurol1997; 38 Suppl 2: 2\u20137.","DOI":"10.1159\/000113469"},{"key":"key\n\t\t\t\t20170624065651_AWF251C81","doi-asserted-by":"crossref","unstructured":"Yamazaki M, Arai Y, Baba M, Iwatsubo T, Mori O, Katayama Y, et al. \u03b1\u2010Synuclein inclusions in amygdala in the brains of patients with the parkinsonism\u2013dementia complex of Guam. J Neuropathol Exp Neurol2000; 59: 585\u201391.","DOI":"10.1093\/jnen\/59.7.585"},{"key":"key\n\t\t\t\t20170624065651_AWF251C82","doi-asserted-by":"crossref","unstructured":"Yesavage JA, Brink TL, Rose TL, Lum O, Huang V, Adey M, et al. Development and validation of a geriatric depression screening scale: a preliminary report. J Psychiatr Res1983; 17: 37\u201349.","DOI":"10.1016\/0022-3956(82)90033-4"},{"key":"key\n\t\t\t\t20170624065651_AWF251C83","doi-asserted-by":"crossref","unstructured":"Yilmazer\u2010Hanke DM, Wolf HK, Schramm J, Elger CE, Wiestler OD, Bl\u00fcmcke I. Subregional pathology of the amygdala complex and entorhinal region in surgical specimens from patients with pharmacoresistant temporal lobe epilepsy. J Neuropathol Exp Neurol2000; 59: 907\u201320.","DOI":"10.1093\/jnen\/59.10.907"},{"key":"key\n\t\t\t\t20170624065651_AWF251C84","doi-asserted-by":"crossref","unstructured":"Young AW, Aggleton JP, Hellawell DJ, Johnson M, Broks P, Hanley JR. Face processing impairments after amygdalotomy. Brain1995; 118: 15\u201324.","DOI":"10.1093\/brain\/118.1.15"}],"container-title":["Brain"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/brain\/article-pdf\/125\/11\/2431\/17872786\/awf251.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,3,10]],"date-time":"2020-03-10T20:05:12Z","timestamp":1583870712000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/brain\/article-lookup\/doi\/10.1093\/brain\/awf251"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,11]]},"references-count":84,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2002,11]]},"published-print":{"date-parts":[[2002,11]]}},"URL":"https:\/\/doi.org\/10.1093\/brain\/awf251","relation":{},"ISSN":["1460-2156","0006-8950"],"issn-type":[{"value":"1460-2156","type":"electronic"},{"value":"0006-8950","type":"print"}],"subject":[],"published":{"date-parts":[[2002,11]]}}}